KeraNatural®

On-demand training & resources

Product information

KeraNatural®

On-demand training & resources

Product information

KeraNatural®

Eversight Academy has curated this free on-demand training to help you best serve your patients. Let us help you seamlessly adopt KeraNatural for the treatment of advanced keratoconus, even in patients with thin corneas.

KeraNatural surgery follows the Istanbul protocol nomogram for ICRS (pictured).

Source: Cataract & Refractive Surgery Today | February 2021

Basic surgical steps include:

Create circular channel manually or with a femtosecond laser with two incisions located 180° apart
Push the ring or arc in gently from one side of the channel with a blunt rod
Pull the segment through from the opposite incision with a reverse Sinskey hook
Trim the ends of the tissue and position within the channel
Optional instruments: Aylin KN Forceps and Kilic KN Tunnel Separator

The KeraNatural procedure has high biocompatibility, minimal extrusion risk and can be reversed or adjusted as needed. Order today to have this sterile, precut tissue on hand when needed.

Request tissue

Eversight Academy has curated this free on-demand training to help you best serve your patients. Let us help you seamlessly adopt BrightMEM for anterior keratoplasty.

BrightMEM™

BrightMEM by Brightstar Therapeutics is a durable, acellular Decemet’s membrane with proliferative proteins. It forms a new foundation for the ocular surface, protecting the stroma from degradation, promoting regeneration of the corneal epithelium and optimizing limbal stem cell growth.

BrightMEM offers novel treatment for limbal stem cell deficiency (LSCD) and complex ocular surface disease (OSD). Patients living with these complex disease states often present with comorbidities, suffer poor vision and experience chronic eye pain and discomfort.

BrightMEM anterior keratoplasty (BMAK) is a simple on-lay procedure utilizing the decellularized corneal graft. The optically clear graft helps form a new foundation for the ocular surface while also reducing pain.

Preclinical data show limbal stem cell and epithelium support and protection from stromal melting. Early clinical results demonstrate re-epithelization without any serious tissue-related adverse reactions.